Sign in Subscribe
Medical equipment industry

Isolyser Company Receives Patent for Liquid Treatment System Products

Strategic Insights

— 1 min read

Isolyser Company, a leading provider of medical waste management solutions, has made a significant breakthrough in its line of Liquid Treatment System (LTS) products. The company has received a formal notice of allowance from the U.S. Patent and Trademark Office for its composition of matter patent, which covers the unique combination of chemical components in the LTS product. This innovation enables the LTS product to absorb and solidify infectious liquid waste without mechanical intervention, making it a cost-effective and fast-response solution for hospitals and other healthcare facilities.

Key Takeaways:

  • Isolyser Company has received a patent for its Liquid Treatment System (LTS) products, which can convert potentially infectious liquid waste into solid waste suitable for landfill disposal.
  • LTS products are designed to work across a wide pH range and electrolyte concentration, and can absorb and solidify without mechanical intervention.
  • The LTS product has been a successful part of Isolyser's product line, with Robert L. Taylor, chairman, president and chief executive officer, citing increased sales and profitability as benefits of the patent.
  • Isolyser's expertise in polymer chemistry has enabled it to develop and manufacture a range of products, including OREX Degradable products which can be dissolved after use for safe disposal.
  • Isolyser is committed to taking a life cycle approach to product development, from initial product development through final disposal, to provide cost-effective solutions and reduce waste generation.

Statistics:

  • The U.S. Patent and Trademark Office has issued a formal notice of allowance for Isolyser's patent application.
  • LTS products have been successfully used in hospitals and other healthcare facilities to manage infectious liquid waste.
  • Isolyser's OREX Degradable products have been designed to provide protection for hospital staff, patients, and the environment.
  • The company's innovative approach has resulted in increased sales and profits for the LTS product.
  • Isolyser aims to reduce waste generation and provide cost-effective solutions for healthcare facilities through its range of products.

Sources:

  • "Isolyser Company, Inc. (NASDAQ/NM:OREX) Announces Receipt of Formal Notice of Allowance for Patent on Liquid Treatment System Products." Business Wire, January 31, 1995.

Read more